Literature DB >> 12805098

Oligophrenin 1 (OPHN1) gene mutation causes syndromic X-linked mental retardation with epilepsy, rostral ventricular enlargement and cerebellar hypoplasia.

Carsten Bergmann1, Klaus Zerres, Jan Senderek, Sabine Rudnik-Schoneborn, Thomas Eggermann, Martin Häusler, Michael Mull, Vincent T Ramaekers.   

Abstract

We identified an oligophrenin 1 (OPHN1) gene mutation in a family with five brothers affected by a recognizable pattern of clinical and neuroradiological hallmarks. The distinctive phenotype comprised moderate to severe mental retardation, myoclonic-astatic epilepsy, ataxia, strabismus and hypogenitalism. Neuroimaging displayed fronto-temporal atrophy with rostral enlargement of the lateral ventricles, lower vermian agenesis and asymmetric cerebellar hypoplasia. Mutation analysis of the OPHN1 gene on Xq12 disclosed a genomic deletion of exon 19 causing a frameshift. Notably, OPHN1 mutations have been previously reported as a rare cause of non-syndromic X-linked mental retardation. Our findings, however, indicate that OPHN1 mutations result in a recognizable syndrome. In addition, identification of OPHN1 as a further gene associated with epileptic seizures will help to unravel aetiologic factors of epilepsy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805098     DOI: 10.1093/brain/awg173

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  38 in total

Review 1.  Novel approaches to studying the genetic basis of cerebellar development.

Authors:  Samin A Sajan; Kathryn E Waimey; Kathleen J Millen
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

Review 2.  Rho-linked genes and neurological disorders.

Authors:  Nael Nadif Kasri; Linda Van Aelst
Journal:  Pflugers Arch       Date:  2007-11-15       Impact factor: 3.657

3.  Rapid synthesis of the X-linked mental retardation protein OPHN1 mediates mGluR-dependent LTD through interaction with the endocytic machinery.

Authors:  Nael Nadif Kasri; Akiko Nakano-Kobayashi; Linda Van Aelst
Journal:  Neuron       Date:  2011-10-20       Impact factor: 17.173

4.  From single-SNP to wide-locus: genome-wide association studies identifying functionally related genes and intragenic regions in small sample studies.

Authors:  Knut M Wittkowski; Vikas Sonakya; Tingting Song; Martin P Seybold; Mehdi Keddache; Martina Durner
Journal:  Pharmacogenomics       Date:  2013-03       Impact factor: 2.533

Review 5.  Seizures and X-linked intellectual disability.

Authors:  Roger E Stevenson; Kenton R Holden; R Curtis Rogers; Charles E Schwartz
Journal:  Eur J Med Genet       Date:  2012-02-08       Impact factor: 2.708

6.  Altered prefrontal cortical MARCKS and PPP1R9A mRNA expression in schizophrenia and bipolar disorder.

Authors:  Glenn T Konopaske; Sivan Subburaju; Joseph T Coyle; Francine M Benes
Journal:  Schizophr Res       Date:  2015-03-07       Impact factor: 4.939

7.  Endophilin A1 induces different membrane shapes using a conformational switch that is regulated by phosphorylation.

Authors:  Mark R Ambroso; Balachandra G Hegde; Ralf Langen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

8.  Preliminary evaluation of accelerated microscopic diffusional kurtosis imaging (μDKI) in a rodent model of epilepsy.

Authors:  Yang Ji; Dongshuang Lu; Limin Wu; Bensheng Qiu; Yi-Qiao Song; Phillip Zhe Sun
Journal:  Magn Reson Imaging       Date:  2018-10-20       Impact factor: 2.546

9.  ROCK/PKA Inhibition Rescues Hippocampal Hyperexcitability and GABAergic Neuron Alterations in a Oligophrenin-1 Knock-Out Mouse Model of X-Linked Intellectual Disability.

Authors:  Irene Busti; Manuela Allegra; Cristina Spalletti; Chiara Panzi; Laura Restani; Pierre Billuart; Matteo Caleo
Journal:  J Neurosci       Date:  2020-02-25       Impact factor: 6.167

Review 10.  A developmental and genetic classification for midbrain-hindbrain malformations.

Authors:  A James Barkovich; Kathleen J Millen; William B Dobyns
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.